← Leaderboards
Jennifer R Grandis
University Of Pittsburgh At Pittsburgh
$109,711,044
Attributed
$113,431,253
Total exposure
26
Grants
17
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $25.8M · FY2005–24$50M$37.5M$25M$12.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$150,499,906 · 27
By mechanism
UL1$75,052,500 · 2
P50$40,703,080 · 8
R01$18,432,807 · 5
R35$6,177,744 · 1
KL2$5,717,000 · 1
T32$2,481,980 · 2
Top collaborators
- Daniel E Johnson10 shared
- Robert L Ferris6 shared
- Katherine Ann Skorupski5 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Dong Moon Shin$11,702,631
- Robert L Ferris$24,076,317
Others in their field
Top investigators on “Head And Neck Cancer”
- Walter John Curran · Thomas Jefferson University$111,090,486
- Norman Wolmark · Nsabp Foundation, Inc.$59,047,729
- David Heimbrook · Leidos Biomedical Research, Inc.$56,561,099
- Robert S Mannel · University Of Oklahoma Hlth Sciences Ctr$42,566,636
- Charles A Coltman · Southwest Oncology Group$36,988,659
- James J. Dignam · University Of Chicago$35,003,821
Research focus
Head And Neck CancerHead And Neck Squamous Cell CarcinomaMalignant NeoplasmsEpidermal Growth Factor ReceptorFundingMediatingSignal TransductionProgramsTumorClinical ResearchHead And Neck StructureGrowthPre-Clinical ModelReportingResearch PersonnelTranslational ResearchSquamous Cell CarcinomaGrowth Factor ReceptorsPathway InteractionsInnovationMutationBaseResistanceUniversities
Grant awards (159)
Integrating genomics and the protein interactome for HPV+ head and neck cancer therapy$911,539
R35 · FY2024 · CA · contact PI
Integrating genomics and the protein interactome for HPV+ head and neck cancer therapy$949,621
R35 · FY2023 · CA · contact PI
PI3K Pathway Mutations in Head and Neck Cancer$641,113
R01 · FY2023 · DE · contact PI
Targeting STAT3 to enhance anti-tumor immunity$636,402
R01 · FY2023 · DE
Integrating genomics and the protein interactome for HPV+ head and neck cancer therapy$949,621
R35 · FY2022 · CA · contact PI
PI3K Pathway Mutations in Head and Neck Cancer$634,703
R01 · FY2022 · DE · contact PI
Targeting STAT3 to enhance anti-tumor immunity$630,039
R01 · FY2022 · DE
Integrating genomics and the protein interactome for HPV+ head and neck cancer therapy$969,000
R35 · FY2021 · CA · contact PI
PI3K Pathway Mutations in Head and Neck Cancer$641,113
R01 · FY2021 · DE · contact PI
Targeting STAT3 to enhance anti-tumor immunity$636,402
R01 · FY2021 · DE
Integrating genomics and the protein interactome for HPV+ head and neck cancer therapy$769,993
R35 · FY2020 · CA · contact PI
PI3K Pathway Mutations in Head and Neck Cancer$645,333
R01 · FY2020 · DE · contact PI
Targeting STAT3 to enhance anti-tumor immunity$636,402
R01 · FY2020 · DE
Head and Neck Cancer SPORE$2,127,841
P50 · FY2019 · CA
Integrating genomics and the protein interactome for HPV+ head and neck cancer therapy$934,594
R35 · FY2019 · CA · contact PI
PI3K Pathway Mutations in Head and Neck Cancer$648,229
R01 · FY2019 · DE · contact PI
Targeting STAT3 to enhance anti-tumor immunity$633,201
R01 · FY2019 · DE
Optimization of STAT3 Decoy Delivery for Head and Neck Cancer Treatment$140,473
P50 · FY2019 · CA · contact PI
Head and Neck Cancer SPORE$2,300,000
P50 · FY2018 · CA
Integrating genomics and the protein interactome for HPV+ head and neck cancer therapy$693,376
R35 · FY2018 · CA · contact PI
PI3K Pathway Mutations in Head and Neck Cancer$372,693
R01 · FY2018 · DE · contact PI
STAT Mediated TGF-a/EGFR Signaling in Squamous Cell Carcinomas of Head & Neck$320,250
R01 · FY2018 · CA · contact PI
Optimization of STAT3 Decoy Delivery for Head and Neck Cancer Treatment$105,853
P50 · FY2018 · CA · contact PI
Head and Neck Cancer Program (Project-010)$34,500
P30 · FY2018 · CA · contact PI
Head and Neck Cancer Program (Project-010)$8,614
P30 · FY2018 · CA · contact PI
Head and Neck Cancer Program (Project-010)$3,971
P30 · FY2018 · CA · contact PI
Clinical and Translational Science Institute$17,024,421
UL1 · FY2017 · TR · contact PI
Head and Neck Cancer SPORE$2,293,901
P50 · FY2017 · CA
Clinical and Translational Science Institute$414,706
UL1 · FY2017 · TR · contact PI
PI3K Pathway Mutations in Head and Neck Cancer$372,953
R01 · FY2017 · DE · contact PI
STAT Mediated TGF-a/EGFR Signaling in Squamous Cell Carcinomas of Head & Neck$320,272
R01 · FY2017 · CA · contact PI
GPCR Signaling in SCCHN: Integration with EGFR$289,580
R01 · FY2017 · CA · contact PI
Optimization of STAT3 Decoy Delivery for Head and Neck Cancer Treatment$148,556
P50 · FY2017 · CA · contact PI
Head and Neck Cancer Program (Project-010)$34,500
P30 · FY2017 · CA · contact PI
Developmental Research Program$15,768
P50 · FY2017 · CA · contact PI
Clinical and Translational Science Institute$18,843,751
UL1 · FY2016 · TR · contact PI
Head and Neck Cancer SPORE$2,260,252
P50 · FY2016 · CA
PI3K Pathway Mutations in Head and Neck Cancer$373,207
R01 · FY2016 · DE · contact PI
STAT Mediated TGF-a/EGFR Signaling in Squamous Cell Carcinomas of Head & Neck$321,866
R01 · FY2016 · CA · contact PI
GPCR Signaling in SCCHN: Integration with EGFR$289,454
R01 · FY2016 · CA · contact PI
Optimization of STAT3 Decoy Delivery for Head and Neck Cancer Treatment$157,591
P50 · FY2016 · CA · contact PI
Developmental Research Program$36,962
P50 · FY2016 · CA · contact PI
Head and Neck Cancer Program (Project-010)$34,671
P30 · FY2016 · CA · contact PI
Clinical and Translational Science Institute$19,399,499
UL1 · FY2015 · TR · contact PI
Clinical and Transtional Science Institute$2,858,500
KL2 · FY2015 · TR · contact PI
Head and Neck Cancer SPORE$2,185,000
P50 · FY2015 · CA
PI3K Pathway Mutations in Head and Neck Cancer$343,220
R01 · FY2015 · DE · contact PI
STAT Mediated TGF-a/EGFR Signaling in Squamous Cell Carcinomas of Head & Neck$333,273
R01 · FY2015 · CA · contact PI
GPCR Signaling in SCCHN: Integration with EGFR$289,263
R01 · FY2015 · CA · contact PI
Optimization of STAT3 Decoy Delivery for Head and Neck Cancer Treatment$271,235
P50 · FY2015 · CA · contact PI
Developmental Research Program$73,142
P50 · FY2015 · CA · contact PI
Head and Neck Cancer Program (Project-010)$34,779
P30 · FY2015 · CA · contact PI
Clinical and Transtional Science Institute$1
TL1 · FY2015 · TR · contact PI
Clinical and Translational Science Institute$19,370,123
UL1 · FY2014 · TR · contact PI
Clinical and Transtional Science Institute$2,858,500
KL2 · FY2014 · TR · contact PI
Specialized Program of Research Excellence$2,155,519
P50 · FY2014 · CA
PI3K Pathway Mutations in Head and Neck Cancer$394,033
R01 · FY2014 · DE · contact PI
STAT Mediated TGF-a/EGFR Signaling in Squamous Cell Carcinomas of Head & Neck$311,850
R01 · FY2014 · CA · contact PI
GPCR Signaling in SCCHN: Integration with EGFR$277,200
R01 · FY2014 · CA · contact PI
Administrative Core$123,495
P50 · FY2014 · CA · contact PI
Clinical and Transtional Science Institute$1
TL1 · FY2014 · TR · contact PI
Specialized Program of Research Excellence$2,150,500
P50 · FY2013 · CA · contact PI
Administrative Core$226,201
P50 · FY2013 · CA · contact PI
GPCR Signaling in SCCHN: Integration with EGFR$218,698
R01 · FY2013 · CA · contact PI
Research Training in Otolaryngology$107,282
T32 · FY2013 · DC · contact PI
Specialized Program of Research Excellence$1,993,608
P50 · FY2012 · CA · contact PI
STAT Mediated TGF-a/EGFR Signaling in squamous cell carcinomas of the head & neck$269,843
R01 · FY2012 · CA · contact PI
GPCR Signaling in SCCHN: Integration with EGFR$232,737
R01 · FY2012 · CA · contact PI
Research Training in Otolaryngology$142,924
T32 · FY2012 · DC · contact PI
Administrative Core$134,457
P50 · FY2012 · CA · contact PI
Postdoctoral Research Training In Head And Neck Oncology$123,881
T32 · FY2012 · CA · contact PI
Specialized Program of Research Excellence$2,185,000
P50 · FY2011 · CA · contact PI
STAT Mediated TGF-a/EGFR Signaling in squamous cell carcinomas of the head & neck$269,843
R01 · FY2011 · CA · contact PI
GPCR Signaling in SCCHN: Integration with EGFR$232,815
R01 · FY2011 · CA · contact PI
Specialized Program of Research Excellence$151,500
P50 · FY2011 · CA · contact PI
Postdoctoral Research Training In Head And Neck Oncology$140,274
T32 · FY2011 · CA · contact PI
Administrative Core$137,781
P50 · FY2011 · CA · contact PI
Research Training in Otolaryngology$119,826
T32 · FY2011 · DC · contact PI
Specialized Program of Research Excellence$2,300,000
P50 · FY2010 · CA · contact PI
Specialized Program of Research Excellence$300,000
P50 · FY2010 · CA · contact PI
STAT Mediated TGF-a/EGFR Signaling in squamous cell carcinomas of the head & neck$278,189
R01 · FY2010 · CA · contact PI
GPCR Signaling in SCCHN: Integration with EGFR$240,092
R01 · FY2010 · CA · contact PI
Research Training in Otolaryngology$163,630
T32 · FY2010 · DC · contact PI
Administrative Core$154,671
P50 · FY2010 · CA · contact PI
Postdoctoral Research Training In Head And Neck Oncology$140,043
T32 · FY2010 · CA · contact PI
Research Workshop on the Biology, Prevention and Treatment of Head and Neck Cance$20,000
R13 · FY2010 · DE · contact PI
SPORE in Head and Neck Cancer$1,092,383
P50 · FY2009 · CA · contact PI
SPORE in Head and Neck Cancer$300,000
P50 · FY2009 · CA · contact PI
STAT Mediated TGF-a/EGFR Signaling in squamous cell carcinomas of the head & neck$278,189
R01 · FY2009 · CA · contact PI
GPCR Signaling in SCCHN: Integration with EGFR$240,178
R01 · FY2009 · CA · contact PI
SPORE in Head and Neck Cancer$230,569
P50 · FY2009 · CA · contact PI
Research Training in Otolaryngology$166,559
T32 · FY2009 · DC · contact PI
Postdoctoral Research Training in Head and Neck Oncology$115,022
T32 · FY2009 · CA · contact PI
SPORE in Head and Neck Cancer$2,184,766
P50 · FY2008 · CA · contact PI
TARGETING ACTIVATED STAT3 IN HN CANCER$528,269
P50 · FY2008 · CA · contact PI
SPORE in Head and Neck Cancer$350,000
P50 · FY2008 · CA · contact PI
SPORE in Head and Neck Cancer$350,000
P50 · FY2008 · CA · contact PI
STAT Mediated TGF-a/EGFR Signaling in squamous cell carcinomas of the head & neck$278,189
R01 · FY2008 · CA · contact PI
Stat3 as a Therapeutic Target in Head and Neck Cancer$258,002
R01 · FY2008 · CA · contact PI
GRPR Signaling in SCCHN: Integration with EGFR$230,921
R01 · FY2008 · CA · contact PI
Research Training in Otolaryngology$111,935
T32 · FY2008 · DC · contact PI
Postdoctoral Research Training in Head and Neck Oncology$54,944
T32 · FY2008 · CA · contact PI
SPORE in Head and Neck Cancer$52,930
P50 · FY2008 · CA · contact PI
SPORE in Head and Neck Cancer$2,184,766
P50 · FY2007 · CA · contact PI
TARGETING ACTIVATED STAT3 IN HN CANCER$491,780
P50 · FY2007 · CA · contact PI
SPORE in Head and Neck Cancer$350,000
P50 · FY2007 · CA · contact PI
STAT-Mediated TGFalpha EGFR Signaling in squamous cell carcinoma of head neck$262,670
R01 · FY2007 · CA · contact PI
Stat3 as a Therapeutic Target in Head and Neck Cancer$258,054
R01 · FY2007 · CA · contact PI
GRPR Signaling in SCCHN: Integration with EGFR$242,308
R01 · FY2007 · CA · contact PI
SPORE in Head and Neck Cancer$200,000
P50 · FY2007 · CA · contact PI
Research Training in Otolaryngology$143,746
T32 · FY2007 · DC · contact PI
Postdoctoral Research Training in Head and Neck Oncology$60,452
T32 · FY2007 · CA · contact PI
SPORE in Head and Neck Cancer$2,362,312
P50 · FY2006 · CA · contact PI
GRPR Signaling in SCCHN: Integration with EGFR$397,054
R01 · FY2006 · CA · contact PI
STAT-Mediated TGFalpha EGFR Signaling in SCCHN$270,576
R01 · FY2006 · CA · contact PI
Stat3 as a Therapeutic Target in Head and Neck Cancer$265,813
R01 · FY2006 · CA · contact PI
TARGETING ACTIVATED STAT3 IN HN CANCER$200,486
P50 · FY2006 · CA · contact PI
SPORE in Head and Neck Cancer$200,000
P50 · FY2006 · CA · contact PI
Research Training in Otolaryngology$146,667
T32 · FY2006 · DC · contact PI
Postdoctoral Research Training in Head and Neck Oncology$126,305
T32 · FY2006 · CA · contact PI
SPORE in Head and Neck Cancer$88,643
P50 · FY2006 · CA · contact PI
SPORE in Head and Neck Cancer$2,419,163
P50 · FY2005 · CA
GRPR Signaling in SCCHN: Integration with EGFR$420,100
R01 · FY2005 · CA
STAT-Mediated TGFalpha EGFR Signaling in SCCHN$277,148
R01 · FY2005 · CA
Stat3 as a Therapeutic Target in Head and Neck Cancer$272,262
R01 · FY2005 · CA
TARGETING ACTIVATED STAT3 IN HN CANCER$200,486
P50 · FY2005 · CA
Research Training in Otolaryngology$146,859
T32 · FY2005 · DC
Postdoctoral Research Training in Head and Neck Oncology$60,363
T32 · FY2005 · CA
Conf. on Research Education &Training in Otolaryngology$30,000
R13 · FY2005 · DC
PHI TRIAL OF INTRATUMORAL ANTISENSE EGFR DNA IN ADV HEAD AND NECK SQUAMOUS$17,655
M01 · FY2005 · RR
SPORE in Head and Neck Cancer$2,300,000
P50 · FY2004 · CA
STAT-Mediated TGFalpha EGFR Signaling in SCCHN$277,208
R01 · FY2004 · CA
Stat3 as a Therapeutic Target in Head and Neck Cancer$272,312
R01 · FY2004 · CA
GRPR Signaling in SCCHN: Integration with EGFR$243,745
R01 · FY2004 · CA
TARGETING ACTIVATED STAT3 IN HN CANCER$200,486
P50 · FY2004 · CA
Imaging of EGFR Targeting in Head and Neck Cancer$185,128
R21 · FY2004 · CA
Research Training in Otolaryngology$150,417
T32 · FY2004 · DC
CAREER DEVELOPMENT PROGRAM$150,000
P50 · FY2004 · CA
ADMINISTRATIVE CORE$136,735
P50 · FY2004 · CA
STAT-Mediated TGF alpha EGFR Signaling in SCCHN$278,185
R01 · FY2003 · CA
Imaging of EGFR Targeting in Head and Neck Cancer$185,763
R21 · FY2003 · CA
Research Training in Otolaryngology$87,303
T32 · FY2003 · DC
POSTDOCTORAL RESEARCH TRAINING IN HEAD &NECK ONOCOLOGY$82,991
T32 · FY2003 · CA
Head and neck cancer program$250,404
P30 · FY2002 · CA
STAT MEDIATED TGF ALPHA/EGFR SIGNALING IN SCCHN$229,301
R01 · FY2002 · CA
EFFICACY AND ANTITUMOR MECHANISMS OF EGFR ANTISENSE GENE THERAPY$162,420
P60 · FY2002 · DE
EFFICACY AND ANTITUMOR MECHANISMS OF EGFR ANTISENSE GENE THERAPY$162,420
P60 · FY2002 · DE
POSTDOCTORAL RESEARCH TRAINING IN HEAD &NECK ONOCOLOGY$90,557
T32 · FY2002 · CA
Head and neck cancer program$250,404
P30 · FY2001 · CA
STAT MEDIATED TGF ALPHA/EGFR SIGNALING IN SCCHN$225,170
R01 · FY2001 · CA
EFFICACY AND ANTITUMOR MECHANISMS OF EGFR ANTISENSE GENE THERAPY$178,572
P60 · FY2001 · DE
EFFICACY AND ANTITUMOR MECHANISMS OF EGFR ANTISENSE GENE THERAPY$162,420
P60 · FY2001 · DE
Head and neck cancer program$0
P30 · FY2001 · CA
STAT MEDIATED TGF ALPHA/EGFR SIGNALING IN SCCHN$221,154
R01 · FY2000 · CA
EFFICACY AND ANTITUMOR MECHANISMS OF EGFR ANTISENSE GENE THERAPY$178,572
P60 · FY2000 · DE
Head and neck cancer program$0
P30 · FY2000 · CA
EFFICACY AND ANTITUMOR MECHANISMS OF EGFR ANTISENSE GENE THERAPY$0
P60 · FY2000 · DE
EFFICACY AND ANTITUMOR MECHANISMS OF EGFR ANTISENSE GENE THERAPY$0
P60 · FY2000 · DE
EFFICACY AND ANTITUMOR MECHANISMS OF EGFR ANTISENSE GENE THERAPY$0
P60 · FY2000 · DE